These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 28465241)
1. N-glycan and Alzheimer's disease. Kizuka Y; Kitazume S; Taniguchi N Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241 [TBL] [Abstract][Full Text] [Related]
2. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease. Tomita T Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052 [TBL] [Abstract][Full Text] [Related]
3. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan. Manya H; Endo T Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406 [TBL] [Abstract][Full Text] [Related]
10. A unique glycan-isoform of transferrin in cerebrospinal fluid: A potential diagnostic marker for neurological diseases. Hoshi K; Matsumoto Y; Ito H; Saito K; Honda T; Yamaguchi Y; Hashimoto Y Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2473-2478. PubMed ID: 28711405 [TBL] [Abstract][Full Text] [Related]
11. Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer's disease. Taniguchi N; Takahashi M; Kizuka Y; Kitazume S; Shuvaev VV; Ookawara T; Furuta A Glycoconj J; 2016 Aug; 33(4):487-97. PubMed ID: 27325408 [TBL] [Abstract][Full Text] [Related]
12. The role of protein glycosylation in Alzheimer disease. Schedin-Weiss S; Winblad B; Tjernberg LO FEBS J; 2014 Jan; 281(1):46-62. PubMed ID: 24279329 [TBL] [Abstract][Full Text] [Related]
13. Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer's disease. Akasaka-Manya K; Manya H; Sakurai Y; Wojczyk BS; Kozutsumi Y; Saito Y; Taniguchi N; Murayama S; Spitalnik SL; Endo T Glycobiology; 2010 Jan; 20(1):99-106. PubMed ID: 19776078 [TBL] [Abstract][Full Text] [Related]
14. The Role of APP Akasaka-Manya K; Manya H Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33218200 [TBL] [Abstract][Full Text] [Related]
15. Nuclear signalling by membrane protein intracellular domains: the AICD enigma. Beckett C; Nalivaeva NN; Belyaev ND; Turner AJ Cell Signal; 2012 Feb; 24(2):402-409. PubMed ID: 22024280 [TBL] [Abstract][Full Text] [Related]
17. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203 [TBL] [Abstract][Full Text] [Related]
18. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
19. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease. Guan PP; Wang P Mol Neurobiol; 2023 Jul; 60(7):3617-3632. PubMed ID: 36877359 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein. Kanarek AM; Wagner A; Küppers J; Gütschow M; Postina R; Kojro E FEBS J; 2017 Mar; 284(5):742-753. PubMed ID: 28102934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]